BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 34294014)

  • 1. Association of IL-4 gene VNTR variant with deep venous thrombosis in Behçet's disease and its effect on ocular involvement.
    Inanir A; Tural S; Yigit S; Kalkan G; Pancar GS; Demir HD; Ates O
    Mol Vis; 2013; 19():675-83. PubMed ID: 23559861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between
    Cakmak Genc G; Karakas Celık S; Kocaaga A; Koca R; Dursun A
    Immunol Invest; 2021 Nov; 50(8):906-913. PubMed ID: 32646311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of IL-17 and IL-17 receptor polymorphisms with Behçet's disease in Denizli Province of Turkey.
    Arıkan S; Öztürk O; Duygulu Ş; Atalay EÖ; Atalay A
    Immunol Res; 2023 Aug; 71(4):600-608. PubMed ID: 36701075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Long Non-coding RNA
    Wang X; Zhang Q; Hou S; Qi J; Du L; Li F; Cao Q; Yang P
    Ocul Immunol Inflamm; 2024 Apr; 32(3):336-341. PubMed ID: 36745681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association analysis reveals the associations of NPHP4, TYW1-AUTS2 and SEMA6D for Behçet's disease and HLA-B*46:01 for its intestinal involvement.
    Jung ES; Ellinghaus D; Degenhardt F; Meguro A; Khor SS; Mucha S; Wendorff M; Juzenas S; Mizuki N; Tokunaga K; Kim SW; Lee MG; Schreiber S; Kim WH; Franke A; Cheon JH
    Dig Liver Dis; 2024 Jun; 56(6):994-1001. PubMed ID: 37977914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CTLA-4 exon-1 49 A/G polymorphism and soluble CTLA-4 protein level in egyptian patients with Behçet's disease.
    Abdel Galil SM; Hagrass HA
    Biomed Res Int; 2014; 2014():513915. PubMed ID: 24991555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication Study of the Association of
    Teshigawara T; Meguro A; Takeuchi M; Ishido M; Soejima Y; Hirahara L; Kirino Y; Ohno S; Mizuki N
    Ocul Immunol Inflamm; 2024 May; 32(4):447-453. PubMed ID: 37133403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behçet's: A Disease or a Syndrome? Answer from an Expression Profiling Study.
    Oğuz AK; Yılmaz ST; Oygür ÇŞ; Çandar T; Sayın I; Kılıçoğlu SS; Ergün İ; Ateş A; Özdağ H; Akar N
    PLoS One; 2016; 11(2):e0149052. PubMed ID: 26890122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL2RA rs2104286 and IL2 rs2069762 polymorphisms may be associated with bipolar disorder and its clinical findings.
    Pehlivan S; Aytac HM; Nursal AF; Tuncel FC; Pehlivan M
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(5):441-452. PubMed ID: 37843874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and predictors for cardiovascular system involvement in patients with Behçet's disease.
    Deng Z; Wang X; Li T; Lyu C; Li J; Liu H
    Clin Exp Rheumatol; 2023 Oct; 41(10):1964-1969. PubMed ID: 36762736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using hierarchical similarity to examine the genetics of Behçet's disease.
    Shenoi SJ; Baker EJ
    BMC Res Notes; 2021 Sep; 14(1):353. PubMed ID: 34507623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analyses delineate distinctive immunological pathways and diagnostic signatures for Behcet's disease by leveraging gene microarray data.
    Zhan H; Cheng L; Li H; Liu Y; Huang Y; Li X; Yan S; Li Y
    Immunol Res; 2023 Dec; 71(6):860-872. PubMed ID: 37341899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based practice in Behçet's disease: identifying areas of unmet need for 2014.
    Barry RJ; Markandey B; Malhotra R; Knott H; Joji N; Mubin M; Denniston AK; Murray PI
    Orphanet J Rare Dis; 2014 Jan; 9():16. PubMed ID: 24475935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel nucleotide-binding oligomerization domain 2 genetic marker for Yao syndrome.
    Navetta-Modrov B; Nomani H; Yun M; Yang J; Salvemini J; Aroniadis O; Clark R; Gorevic PD; Yao Q
    J Am Acad Dermatol; 2023 Jul; 89(1):166-168. PubMed ID: 36858152
    [No Abstract]   [Full Text] [Related]  

  • 15. New approaches in immunotherapy of behçet disease.
    Zare Shahneh F; Mohammadian M; Babaloo Z; Baradaran B
    Adv Pharm Bull; 2013; 3(1):9-11. PubMed ID: 24312805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted NOD2 sequencing uncovers JIA misdiagnosis.
    Onuora S
    Nat Rev Rheumatol; 2024 Jan; 20(1):3. PubMed ID: 38030937
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of NOD1, NOD2, PYDC1 and PYDC2 genes with Behcet's disease susceptibility and clinical manifestations.
    Kocaaga A; Cakmak Genc G; Karakas Celık S; Koca R; Dursun A
    Ophthalmic Genet; 2021 Dec; 42(6):691-697. PubMed ID: 34294014
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of
    Kocaaga A; Cakmak Genc G; Karakas Celik S; Piskin İE; Calik M; Dursun A
    J Child Neurol; 2023 Feb; 38(1-2):38-43. PubMed ID: 36544356
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic variation in NOD1/CARD4 and NOD2/CARD15 immune sensors and risk of osteoporosis.
    Soyocak A; Özgen M; Turgut Coşan D; Kurt H; Doğaner F; Armağan O; Değirmenci İ; Şahin Mutlu F
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32578848
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.